Left: Anatomic MR image of breast tumour; Right: Overlays of hyperpolarised  13C-MRI on anatomic images showing pyruvate and lactate in breast cancer

Magnetised molecules used to monitor breast cancer

22 January 2020

A new type of scan that involves magnetising molecules allows doctors to see in real-time which regions of a breast tumour are active, according to research at the ̽»¨Ö±²¥ of Cambridge and published in Proceedings of the National Academy of Sciences.

Read More

Cambridge extends world leading role for medical imaging with powerful new brain and body scanners

24 October 2016

̽»¨Ö±²¥next generation of imaging technology, newly installed at the ̽»¨Ö±²¥ of Cambridge, will give researchers an unprecedented view of the human body – in particular of the myriad connections within our brains and of tumours as they grow and respond to treatment – and could pave the way for development of treatments personalised for individual patients.

Read More
An abdominal tumour (outlined in white) 'feeding on' carbon-13-labelled glucose (orange) provides a means of testing when cancer drugs are effective enough to affect the health of the tumour

Watching the death throes of tumours

25 February 2015

A clinical trial due to begin later this year will see scientists observing close up, in real time – and in patients – how tumours respond to new drugs.

Read More